| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |